keyword
https://read.qxmd.com/read/37120105/prospective-study-of-the-modified-atkins-diet-in-adult-drug-resistant-epilepsy-effectiveness-tolerability-and-adherence
#41
JOURNAL ARTICLE
M I Alanis Guevara, J E García de Alba García, A L López Alanis, A González Ojeda, C Fuentes Orozco
INTRODUCTION: Drug-resistant epilepsy presents high worldwide prevalence and is difficult to control despite the wide variety of available antiepileptic drugs (AED). The modified Atkins diet (MAD) is an additional treatment alternative. Several studies have addressed the use of the ketogenic diet and MAD in children with drug-resistant epilepsy, but insufficient research has been conducted into adults with the same condition. OBJECTIVE: To evaluate the effectiveness and tolerability of, and adherence to, the MAD in adults with drug-resistant epilepsy...
April 27, 2023: Neurología
https://read.qxmd.com/read/37036046/sglt2-inhibitors-and-autophagy-in-diabetes
#42
REVIEW
Habib Yaribeygi, Mina Maleki, Stephen L Atkin, Tannaz Jamialahmadi, Amirhossein Sahebkar
Autophagy is a physiological event in mammalian cells to promote cell survival and efficiency in tissues, but it may turn to be a pathological process in disease conditions such as in diabetes. Chronic hyperglycemia induces aberrant autophagy and promotes cellular death as a main underlying cause of diabetes-related complications. Therefore, autophagy-modifying therapy may be of value to prevent the development of complications. Sodium-glucose cotransporter 2 inhibitors (SGLT2is) are a class of newly introduced antidiabetic drugs that achieve normoglycemia through causing overt glycosuria...
April 10, 2023: Cell Biochemistry and Function
https://read.qxmd.com/read/37029971/international-validation-of-a-venous-leg-ulcer-risk-assessment-tool
#43
JOURNAL ARTICLE
Christina Parker, Kathleen Finlayson, Leanne Atkin, Karen Ousey, Ojan Assadian, Sonja Koller, Amanda Pagan, Emil Schmidt, Helen Edwards
OBJECTIVE: To internationally validate a tool for predicting the risk of delayed healing of venous leg ulcers (VLUs). METHOD: A 10-item tool including sociodemographic factors, venous history, ulcer and lower limb characteristics, compression and mobility items to determine the risk of delayed healing of VLUs has previously been developed and validated in Australia. This study prospectively validated this tool using receiver operating characteristic (ROC) methods; using the area under the curve (AUC) to quantify the discriminatory capability of the tool to analyse the international populations of the UK, Austria and New Zealand...
April 2, 2023: Journal of Wound Care
https://read.qxmd.com/read/37020238/improving-prioritization-processes-for-clinical-practice-guidelines-new-methods-and-an-evaluation-from-the-national-heart-foundation-of-australia
#44
JOURNAL ARTICLE
Brooke Atkins, Tom Briffa, Cia Connell, Amanda K Buttery, Garry L R Jennings
BACKGROUND: Releasing timely and relevant clinical guidelines is challenging for organizations globally. Priority-setting is crucial, as guideline development is resource-intensive. Our aim, as a national organization responsible for developing cardiovascular clinical guidelines, was to develop a method for generating and prioritizing topics for future clinical guideline development in areas where guidance was most needed. METHODS: Several novel processes were developed, adopted and evaluated, including (1) initial public consultation for health professionals and the general public to generate topics; (2) thematic and qualitative analysis, according to the International Classification of Diseases (ICD-11), to aggregate topics; (3) adapting a criteria-based matrix tool to prioritize topics; (4) achieving consensus through a modified-nominal group technique and voting on priorities; and (5) process evaluation via survey of end-users...
April 5, 2023: Health Research Policy and Systems
https://read.qxmd.com/read/37001909/society-for-immunotherapy-of-cancer-sitc-consensus-definitions-for-immune-checkpoint-inhibitor-associated-immune-related-adverse-events-iraes-terminology
#45
JOURNAL ARTICLE
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, Julie R Brahmer, Stephane Champiat, David Feltquate, Lee M Krug, Javid Moslehi, M Catherine Pietanza, Joanne Riemer, Caroline Robert, Elad Sharon, Maria E Suarez-Almazor, Karthik Suresh, Michelle Turner, Jeffrey Weber, Laura C Cappelli
Immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) therapy may vary substantially in their clinical presentation, including natural history, outcomes to treatment, and patterns. The application of clinical guidelines for irAE management can be challenging for practitioners due to a lack of common or consistently applied terminology. Furthermore, given the growing body of clinical experience and published data on irAEs, there is a greater appreciation for the heterogeneous natural histories, responses to treatment, and patterns of these toxicities, which is not currently reflected in irAE guidelines...
March 2023: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/36980195/hdl-associated-proteins-in-subjects-with-polycystic-ovary-syndrome-a-proteomic-study
#46
JOURNAL ARTICLE
Alexandra E Butler, Abu Saleh Md Moin, Željko Reiner, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar, Stephen L Atkin
INTRODUCTION: Serum lipoproteins, with the exception of high-density lipoprotein cholesterol (HDL-C), are increased in polycystic ovary syndrome (PCOS) and their levels may reflect the associated obesity and insulin resistance, but the nature of this association is not fully explained. Therefore, proteomic analysis of key proteins in lipoprotein metabolism was performed. METHODS: In this cohort study, plasma was collected from 234 women (137 with PCOS and 97 controls without PCOS)...
March 9, 2023: Cells
https://read.qxmd.com/read/36958064/comprehensive-study-of-metabolic-changes-induced-by-a-ketogenic-diet-therapy-using-gc-ms-and-lc-ms-based-metabolomics
#47
JOURNAL ARTICLE
Mari Akiyama, Tomoyuki Akiyama, Daisuke Saigusa, Eiji Hishinuma, Naomi Matsukawa, Takashi Shibata, Hiroki Tsuchiya, Atsushi Mori, Yuji Fujii, Yukiko Mogami, Chiho Tokorodani, Kozue Kuwahara, Yurika Numata-Uematsu, Kenji Inoue, Katsuhiro Kobayashi
OBJECTIVE: The ketogenic diet (KD), a high-fat and low-carbohydrate diet, is effective for a subset of patients with drug-resistant epilepsy, although the mechanisms of the KD have not been fully elucidated. The aims of this observational study were to investigate comprehensive short-term metabolic changes induced by the KD and to explore candidate metabolites or pathways for potential new therapeutic targets. METHODS: Subjects included patients with intractable epilepsy who had undergone the KD therapy (the medium-chain triglyceride [MCT] KD or the modified Atkins diet using MCT oil)...
March 16, 2023: Seizure: the Journal of the British Epilepsy Association
https://read.qxmd.com/read/36945385/augmentation-of-a-neuroprotective-myeloid-state-by-hematopoietic-cell-transplantation
#48
Marius Marc-Daniel Mader, Alan Napole, Danwei Wu, Yohei Shibuya, Alexa Scavetti, Aulden Foltz, Micaiah Atkins, Oliver Hahn, Yongjin Yoo, Ron Danziger, Christina Tan, Tony Wyss-Coray, Lawrence Steinman, Marius Wernig
Multiple sclerosis (MS) is an autoimmune disease associated with inflammatory demyelination in the central nervous system (CNS). Autologous hematopoietic cell transplantation (HCT) is under investigation as a promising therapy for treatment-refractory MS. Here we identify a reactive myeloid state in chronic experimental autoimmune encephalitis (EAE) mice and MS patients that is surprisingly associated with neuroprotection and immune suppression. HCT in EAE mice leads to an enhancement of this myeloid state, as well as clinical improvement, reduction of demyelinated lesions, suppression of cytotoxic T cells, and amelioration of reactive astrogliosis reflected in reduced expression of EAE- associated gene signatures in oligodendrocytes and astrocytes...
March 12, 2023: bioRxiv
https://read.qxmd.com/read/36923995/health-related-quality-of-life-in-adults-with-drug-resistant-focal-epilepsy-treated-with-modified-atkins-diet-in-a-randomized-clinical-trial
#49
RANDOMIZED CONTROLLED TRIAL
Magnhild Kverneland, Karl Otto Nakken, Dag Hofoss, Annette Holth Skogan, Per Ole Iversen, Kaja Kristine Selmer, Morten Ingvar Lossius
Ketogenic diet, a high-fat, low-carbohydrate diet, is an established treatment for patients with severe epilepsy. We have previously reported a moderate reduction in seizure frequency after treatment with a modified Atkins diet. This study aimed to see whether dietary therapy impacts patients' health-related quality of life (HRQOL). In a randomized controlled design, we compared the change in self-reported HRQOL among adults with difficult-to-treat epilepsy after a 12-week diet intervention. Thirty-nine patients with drug-resistant focal epilepsy (age = 16-65 years) were randomized to eat a modified Atkins diet with maximum 16 g of carbohydrate per day (diet group, n = 19) or to continue eating habitual diet (control group, n = 20)...
May 2023: Epilepsia
https://read.qxmd.com/read/36910555/branched-and-fenestrated-aortic-endovascular-grafts
#50
REVIEW
Aidan D Atkins, Marvin D Atkins
Endovascular repair of abdominal and descending thoracic aortic aneurysms has become the standard of care due to improvements in morbidity and mortality compared to open surgical repair. Late durability, however, remains an issue because persistent endoleaks can lead to continued aneurysm expansion and eventual rupture, sometimes years following the original repair. Branched, fenestrated, and physician-modified endografts in the thoracic arch and thoracoabdominal aorta have extended the seal zone in order to mitigate the risks of proximal and distal endoleaks...
2023: Methodist DeBakey Cardiovascular Journal
https://read.qxmd.com/read/36906721/impact-of-two-ketogenic-diet-types-in-refractory-childhood-epilepsy
#51
RANDOMIZED CONTROLLED TRIAL
Ali M El-Shafie, Wael A Bahbah, Sameh A Abd El Naby, Zein A Omar, Elsayedamr M Basma, Aya A A Hegazy, Heba M S El Zefzaf
BACKGROUND: Ketogenic diet (KD) refers to any diet in which food composition induces a ketogenic state of human metabolism. OBJECTIVE: To assess short- and long-term efficacy, safety, and tolerability of KD [classic KD and modified Atkins diet (MAD)] in childhood drug-resistant epilepsy (DRE) and to investigate the effect of KD on electroencephalographic (EEG) features of children with DRE. METHODS: Forty patients diagnosed with DRE according to International League Against Epilepsy were included and randomly assigned into classic KD or MAD groups...
December 2023: Pediatric Research
https://read.qxmd.com/read/36859809/coagulation-factor-dysregulation-in-polycystic-ovary-syndrome-is-an-epiphenomenon-of-obesity
#52
JOURNAL ARTICLE
Abu Saleh Md Moin, Thozhukat Sathyapalan, Alexandra E Butler, Stephen L Atkin
OBJECTIVE: Obese women with polycystic ovary syndrome (PCOS) exhibit a hypercoagulable state, with the suggestion that this may be obesity-driven rather than an intrinsic facet of PCOS; however, this has not yet been definitively determined since body mass index (BMI) is so highly correlated with PCOS. Therefore, only a study design where obesity, insulin resistance and inflammation are matched can answer this question. DESIGN: This was a cohort study. Patients Weight and aged-matched nonobese women with PCOS (n = 29) and control women (n = 29) were included...
June 2023: Clinical Endocrinology
https://read.qxmd.com/read/36812889/combinatorial-biomarker-for-predicting-outcomes-to-anti-pd-1-therapy-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma
#53
JOURNAL ARTICLE
Julie Stein Deutsch, Evan J Lipson, Ludmila Danilova, Suzanne L Topalian, Jaroslaw Jedrych, Ezra Baraban, Yasser Ged, Nirmish Singla, Toni K Choueiri, Saurabh Gupta, Robert J Motzer, David McDermott, Sabina Signoretti, Michael Atkins, Janis M Taube
With a rapidly developing immunotherapeutic landscape for patients with metastatic clear cell renal cell carcinoma, biomarkers of efficacy are highly desirable to guide treatment strategy. Hematoxylin and eosin (H&E)-stained slides are inexpensive and widely available in pathology laboratories, including in resource-poor settings. Here, H&E scoring of tumor-infiltrating immune cells (TILplus ) in pre-treatment tumor specimens using light microscopy is associated with improved overall survival (OS) in three independent cohorts of patients receiving immune checkpoint blockade...
February 21, 2023: Cell reports medicine
https://read.qxmd.com/read/36775798/metabolomic-proteomic-and-transcriptomic-changes-in-adults-with-epilepsy-on-modified-atkins-diet
#54
JOURNAL ARTICLE
Dominique F Leitner, Yik Siu, Aryeh Korman, Ziyan Lin, Evgeny Kanshin, Daniel Friedman, Sasha Devore, Beatrix Ueberheide, Aristotelis Tsirigos, Drew R Jones, Thomas Wisniewski, Orrin Devinsky
OBJECTIVE: High-fat and low-carbohydrate diets can reduce seizure frequency in some treatment-resistant epilepsy patients, including the more flexible modified Atkins diet (MAD), which is more palatable, mimicking fasting and inducing high ketone body levels. Low-carbohydrate diets may shift brain energy production, particularly impacting neuron- and astrocyte-linked metabolism. METHODS: We evaluated the effect of short-term MAD on molecular mechanisms in adult epilepsy patients from surgical brain tissue and plasma compared to control participants consuming a nonmodified higher carbohydrate diet (n = 6 MAD, mean age = 43...
February 12, 2023: Epilepsia
https://read.qxmd.com/read/36749276/a-bibliometric-analysis-of-the-global-trends-and-hotspots-for-the-ketogenic-diet-based-on-citespace
#55
JOURNAL ARTICLE
Ran Ye, Yanfei Cheng, Yingying Ge, Guihua Xu, Wenjing Tu
The ketogenic diet (KD) is a potential nutritional therapy that is frequently utilized in various conditions. More and more studies are being done on KD in recent years. However, as far as we know, few studies have made an effort to offer a thorough synthesis and assessment of this topic. This paper aims to do a rigorous and thorough evaluation of the knowledge structure, development trend, and research hotspot of scientific outputs connected to KD. The bibliographic records connected to KD from January 1, 2001 to April 22, 2022 were collected using the core collection database of Web of Science...
February 3, 2023: Medicine (Baltimore)
https://read.qxmd.com/read/36716045/efficacy-and-safety-of-dietary-therapies-for-childhood-drug-resistant-epilepsy-a-systematic-review-and-network-meta-analysis
#56
JOURNAL ARTICLE
Nagita Devi, Priyanka Madaan, Nidhun Kandoth, Dipika Bansal, Jitendra Kumar Sahu
IMPORTANCE: Despite advances in the understanding of dietary therapies in children with drug-resistant epilepsy, no quantitative comparison exists between different dietary interventions. OBJECTIVE: To evaluate the comparative efficacy and safety of various dietary therapies in childhood drug-resistant epilepsy. DATA SOURCES: Systematic review and network meta-analysis (frequentist) of studies in PubMed, Embase, Cochrane, and Ovid published from inception to April 2022 using the search terms ketogenic diet, medium chain triglyceride diet, modified Atkins diet, low glycemic index therapy, and refractory epilepsy...
March 1, 2023: JAMA Pediatrics
https://read.qxmd.com/read/36653879/identifying-effect-modifiers-of-car-t-cell-therapeutic-efficacy-a-systematic-review-and-individual-patient-data-meta-analysis-protocol
#57
JOURNAL ARTICLE
Manoj M Lalu, Natasha Kekre, Joshua Montroy, Maryam Ghiasi, Kevin Hay, Scott McComb, Risini Weeratna, Harold Atkins, Brian Hutton, Ayel Yahya, Ashish Masurekar, Mohamad Sobh, Dean A Fergusson
BACKGROUND: Chimeric antigen receptor T cell therapy (CAR-T) represents a promising and exciting new therapy for hematologic malignancies, where prognosis for relapsed/refractory patients remains poor. Encouraging results from clinical trials have often been tempered by heterogeneity in response to treatment among patients, as well as safety concerns including cytokine release syndrome. The identification of specific patient or treatment-specific factors underlying this heterogeneity may provide the key to the long-term sustainability of this complex and expensive therapy...
January 19, 2023: Systematic Reviews
https://read.qxmd.com/read/36599697/safety-efficacy-and-tolerability-of-modified-atkins-diet-in-persons-with-drug-resistant-epilepsy-a-randomized-controlled-trial
#58
RANDOMIZED CONTROLLED TRIAL
Mala Manral, Rekha Dwivedi, Sheffali Gulati, Kirandeep Kaur, Ashima Nehra, Ravindra Mohan Pandey, Ashish Datt Upadhyay, Savita Sapra, Manjari Tripathi
BACKGROUND AND OBJECTIVES: Modified Atkins diet (MAD) has emerged as an adjuvant therapy in drug-resistant epilepsy (DRE). Most studies are in children; there is limited evidence for DRE in adults. This study aimed to investigate whether MAD along with standard drug therapy (SDT) was indeed more effective than SDT alone in reducing seizure frequency and improving psychological outcomes at 6 months in adolescents and adults with DRE (nonsurgical). METHODS: A prospective randomized controlled trial was conducted at tertiary care referral center in India...
March 28, 2023: Neurology
https://read.qxmd.com/read/36501006/ketogenic-diets-in-the-management-of-lennox-gastaut-syndrome-review-of-literature
#59
REVIEW
Urszula Skrobas, Piotr Duda, Łukasz Bryliński, Paulina Drożak, Magdalena Pelczar, Konrad Rejdak
Epilepsy is an important medical problem with approximately 50 million patients globally. No more than 70% of epileptic patients will achieve seizure control after antiepileptic drugs, and several epileptic syndromes, including Lennox-Gastaut syndrome (LGS), are predisposed to more frequent pharmacoresistance. Ketogenic dietary therapies (KDTs) are a form of non-pharmacological treatments used in attempts to provide seizure control for LGS patients who experience pharmacoresistance. Our review aimed to evaluate the efficacy and practicalities concerning the use of KDTs in LGS...
November 23, 2022: Nutrients
https://read.qxmd.com/read/36471628/does-the-ketogenic-ratio-matter-when-using-ketogenic-diet-therapy-in-pediatric-epilepsy
#60
REVIEW
Suvasini Sharma, Robyn Whitney, Eric H Kossoff, Rajesh RamachandranNair
The ketogenic diet (KD) is a widely used therapeutic option for individuals with medically refractory epilepsy. As the diet's name implies, ketosis is a historically important component of the diet, but it is not well understood how important ketosis is for seizure control. The ketogenic ratio is defined as the ratio of fat to carbohydrate plus protein by weight in the diet (grams). Traditionally, the classic KD contains a 4:1 ratio, and a very high proportion of fat in the diet. The classic KD, with its high proportion of fat and limited carbohydrate intake can be restrictive for patients with epilepsy...
February 2023: Epilepsia
keyword
keyword
111927
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.